Scalp Hypothermia During Chemotherapy to Prevent Hair Loss — NCD 147 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 147 governing scalp hypothermia during chemotherapy, effective March 7, 2026. Scalp cooling is covered as a supply incident to a physician's service — but no separate charge is recognized.

This matters immediately for oncology billing teams. The CMS scalp hypothermia coverage policy under NCD 147 draws a hard line: these services and devices are covered, but only as bundled supplies. If your charge capture is built to bill scalp hypothermia as a standalone line item, you will get denied. This policy does not list specific CPT or HCPCS codes, which creates its own set of problems — and we'll get into those.

Quick-Reference Table

CMS Scalp Hypothermia Coverage Criteria and Medical Necessity Requirements 2026

The core coverage policy here is straightforward, but the billing implication is easy to miss.

CMS covers scalp hypothermia during chemotherapy — including ice-filled bags, bandages, and specially designed cooling devices — under two benefit categories. Those are "incident to a physician's professional service" and "outpatient hospital services incident to a physician's service." Both are supply-level coverage, not procedure-level coverage.

The medical necessity basis is established. Keeping the scalp cool during chemotherapy reduces the risk of chemotherapy-induced alopecia. CMS recognizes that. What CMS does not recognize is a separate reimbursement line for it.

The exact language from NCD 147 is blunt: supplies "of the kind commonly furnished without a separate charge" are covered, but "no separate charge for them would be recognized." That's not ambiguity — that's a flat prohibition on separate billing.

This is where prior authorization questions typically surface for oncology teams. Because scalp hypothermia falls under incident-to coverage, there is no separate prior authorization pathway for the device or supply itself. It moves with the chemotherapy administration encounter. If your team has been routing prior auth requests specifically for scalp cooling devices, stop. That's not the right workflow under this coverage policy.

Whether scalp hypothermia is covered under Medicare depends entirely on whether it's billed correctly — bundled into the chemotherapy encounter, not as a standalone charge. That distinction is the whole game here.

CMS Scalp Hypothermia Exclusions and Non-Covered Indications

NCD 147 doesn't frame this as an exclusion in the traditional sense — it frames it as a billing restriction.

The device or supply itself isn't excluded from coverage. What's excluded is the separate charge. That's a meaningful difference. A claim denial here won't come back coded as "non-covered service." It'll come back as a billing error — an unbundling violation or an improperly structured claim.

There's no experimental or investigational designation attached to scalp hypothermia under this policy. CMS isn't questioning whether it works. The agency is simply saying it's a supply, not a billable procedure.

If your practice has been treating scalp cooling devices as durable medical equipment and billing them separately — or if a vendor has encouraged you to bill them that way — NCD 147 as modified does not support that approach. Talk to your compliance officer before March 7, 2026 if you have any DME-related charge capture built around these devices.

Coverage Indications at a Glance

CMS Scalp Hypothermia Billing Guidelines and Action Items 2026

Here's what your billing team needs to do before the effective date of March 7, 2026.

1. Audit your charge capture for any standalone scalp hypothermia charges.
Search your charge master for any line items tied to scalp cooling, scalp hypothermia, or cooling cap devices. If you find them, flag them for removal or reclassification. A separate charge here is a direct path to claim denial.

2. Confirm how your EHR or billing system handles incident-to supplies.
Scalp hypothermia billing lives inside the chemotherapy administration encounter, not outside it. Make sure your system isn't auto-generating a separate charge for the cooling device when the chemotherapy administration is billed.

3. Do not attempt to bill cooling devices as DME.
Some device vendors have promoted scalp cooling systems as billable DME. NCD 147 does not support that. These devices are covered as incident-to supplies in the outpatient or physician setting — not as separately payable equipment. If a vendor is telling you otherwise, get that in writing and run it by your compliance officer.

4. Review your remittance history for past denials on scalp hypothermia charges.
If you've billed this separately before March 7, 2026 and received denials, those denials are consistent with NCD 147. Don't rework those claims into a new separate billing structure. The answer is to bundle correctly going forward.

5. Brief your oncology coders on the absence of specific codes.
NCD 147 does not list specific CPT or HCPCS codes for scalp hypothermia. That's not an oversight you can work around by finding a code that "fits." The absence of codes reinforces the bundle — there's no code to bill because there's no separate charge to recognize. Make sure your coders understand this is intentional policy structure, not a gap to fill.

6. Update your payer policy reference materials to reflect the March 7, 2026 effective date.
If your team uses internal coverage quick-reference sheets for oncology encounters, update them now. Note that scalp hypothermia is covered incident-to, no separate charge, no listed procedure codes.

CPT, HCPCS, and ICD-10 Codes for Scalp Hypothermia Under NCD 147

This is where things get important to say plainly: NCD 147 does not list specific CPT, HCPCS Level II, or ICD-10-CM codes.

That's not a data gap on our end. The actual policy contains no code assignments. This is consistent with how CMS structures certain supply-level national coverage determinations — the service is covered as part of an existing encounter, so there's no separate code to assign.

What This Means for Your Coding Team

The absence of codes is itself the instruction. Scalp hypothermia during chemotherapy has no standalone procedure code recognized under this policy. Your coders should not be hunting for a miscellaneous supply code or an unlisted procedure code to capture this separately. Doing so creates unbundling exposure.

The chemotherapy administration codes your team already bills — whatever CPT codes govern the infusion encounter — remain the correct framework. Scalp hypothermia is a supply bundled into that encounter.

A Note on HCPCS Codes for Cooling Devices

Some commercially marketed scalp cooling systems have associated HCPCS codes used in other billing contexts. NCD 147 does not reference or recognize those codes for separate Medicare reimbursement. If you're seeing vendor materials that suggest otherwise, verify directly against the NCD 147 policy text at CMS.gov before billing.

If your practice bills a significant volume of scalp hypothermia-related encounters and you're uncertain how to document the supply in the medical record without a separate charge, that's worth a conversation with your MAC. Medicare Administrative Contractors sometimes issue local coverage determination guidance or billing memos that add clarity to NCD-level policies like this one. Check with your MAC before assuming silence means flexibility.